Jianan Wang
Latest contributions
The Top Late-Breaking Trials - Part 2
16 Nov 2025 – From PCR London Valves 2025
This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights...
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
TAVI innovations: latest breakthroughs from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.
Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...
PCR Valves e-Course 2020 Hotline - Global EXPAND study, DragonFly valve repair device, MITRAL trial...
23 Nov 2020 – From PCR Valves e-Course 2020
- Contemporary, real-world, clinical outcomes with the next generation MitraClip (NTR/XTR) system in patients with secondary MR: results from the global EXPAND study - J. Hausleiter
- Transcatheter mitral edge-to-edge repair with the DragonFly valve repair device - early feasibility study - J. Wang
- Two-year outcomes of mitral valve-in-MAC, valve-in-ring...
